logo

The COVID-NMA initiative
A living mapping and living systematic review of Covid-19 trials

COVID-NMA is an international research initiative supported by the WHO and Cochrane.

We provide a living mapping of COVID-19 trials. We are also conducting living evidence synthesis on preventive interventions, treatments and vaccines for COVID-19 to assist decision makers.

See the description of our model here and our living review protocol here.

LIVING MAPPING OF TRIALS

(i.e., trials registered on the WHO platform)
Updated weekly

3239
Randomized Trials
1564 RCTs recruiting

2608
RCTs on treatments
(1308 recruiting)

340
RCTs on prevention
(138 recruiting)

291
RCTs on vaccines
(118 recruiting)

LIVING SYNTHESIS OF PUBLISHED TRIALS

(include both articles and preprints)
Updated daily

330
RCTs with complete data extraction and results
included in our evidence synthesis

263
RCTs on treatments

17
RCTs on prevention

50
RCTs on vaccines

Weekly update

July 12 to July 16, 2021: see the update here.

Newsletter

To receive updates on our project, please subscribe below.

This work received some funding from the Agence Nationale de la Recherche (ANR), the World Health Organization (WHO), Cochrane France, Center of Research in Epidemiology and StatisticS (CRESS), Centre d’Epidémiologie Clinique (GHU Cochin, Hôtel Dieu, Assistance Publique Hôpitaux de Paris (APHP) and Université de Paris), Centre national de la recherche scientifique (CNRS) and the Federal Ministry of Health, Germany